|
| Exchange Received Time 14/08/2018 10:39:06 Exchange Disseminated Time 14/08/2018 10:39:15 Time Taken 00:00:09 | Dear Sir/Madam,
Sub : Regulation 30 &33 of the SEBI ( Listing Obligations and Disclosure ) Regulations, 2015 - Unaudited Results for the first quarter ended 30.06.2018
We write to inform that the board in its meeting approved the following:
a. Unaudited financial results of the Company for the first quarter ended 30th June 2018
b. Trial production at the New 100% Export Oriented Unit at Tiptur in Karnataka dedicated for Marigold process is underway and the Commercial Production would commence by first week of September 2018.
c. Board has decided to suspend and reevaluate its OTC brand Nutraceutical business in view of difficult market conditions.
Further, we enclose herewith the Limited Review report issued by M/s PKF Sridhar & Santhanam LL.P, Chartered Accountants, Chennai on the above results. The meeting of the Board of Directors concluded at 10.40 a.m. today.
This may please be taken on record.
|
|
|